1[1]Okabe H,Ikai Ⅰ,Matsuo K,et al. Comprehensive allelotype study of hepatocellular carcinoma:potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and-negative tumors. Hepatology, 2000,31 ( 5 ): 1073-1079.
2[2]Wong N,Lai P,Pang E,et al. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res, 2000, 6 (10) :4000-4009.
3[3]Lee YI, Lee S,Das GC,et al. Activation of the insulin-like growth factor Ⅰ transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.Oncogene,2000,19(33) :3717-3726.
4[4]Park US,Park SK,Lee YI,et al. Hepatitis B virus-X protein upregulates the expressionof p21waf1/cipl and prolongs G1->S transition via a p53-independent pathway in human hepatoma cells. Oncogene, 2000,19 (30): 3384-3394.
5[5]Feo F, Pascale RM, Simile MM, et al. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit Rev Oncog, 2000,11 (1): 19-62.
6[6]Chen TC,Hsieh LL,Kuo TT,et al. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwan Residents hepatocellular carcinoma. Anticancer Res,2000,20 ( 3A ) :1621-1626.
7[7]Iida M, Iwata H, Inoue H, et al. Correlation between Bc1-2 overexpression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C 3F1 mouse. Toxicol Sci, 2000,56 (2):297-302.
8[8]Lau WY, Lai PB, Leung MF, et al. Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol Res, 2000,12(2) : 59-69.
9[9]van Hal NL,Vorst O,Van Houwelingen AM,et al. The application of DNA microarrays in gene expression analysis. J Biotechnol, 2000, 78(3): 271-280.
10[10]Hirschowitz EA,Naama HA,Evoy D,et al. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma. Cancer Gene Ther,1999,6(6) :491-498.